Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers

Journal of Addiction Medicine and Therapeutic Science

Review Article

Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers3

Background: Since its U.S. FDA approval in 2002, buprenorphine has been available for maintenance
treatment of opiate dependence in primary care physicians’ offices. Though buprenorphine was intended to
facilitate access to treatment, disparities in utilization have emerged; while buprenorphine treatment is widely
used in private care setting, public healthcare integration of buprenorphine lags behind.
Results: Through a review of the literature, we found that U.S. disparities are partly due to a shortage of
certified prescribers, concern of patient diversion, as well as economic and institutional barriers. Disparity of
buprenorphine treatment dissemination is concerning since buprenorphine treatment has specific characteristics
that are especially suited for low-income patient population in public sector healthcare such as flexible dosing
schedules, ease of concurrently treating co-morbidities such as HIV and hepatitis C, positive patient attitudes

towards treatment, and the potential of reducing addiction treatment stigma.

http://www.peertechz.com/Addiction-Medicine-Therapeutic-Science/pdf/JAMTS-1-108.pdf

Comments

Popular posts from this blog

Anterior Tarsal Tunnel Syndrome with Presence of Accessory Deep Peroneal Nerve: Case Report

Sarcoidosis-Lymphoma Syndrome presenting by severe Cholestatic Hepatitis